Tag: disease

Chronic Obstructive Pulmonary Disease Drugs Market | Industry Analysis By Global COVID-19 Impact On Healthcare Sector And Business

The MarketWatch News Department was not involved in the creation of this content.

Sep 23, 2020 (The Expresswire) —
Fortune Business Insights Published “Chronic Obstructive Pulmonary Disease Drugs Market” 2020 Size, Share Estimation, Growth Projection, Emerging Trends And Global Industry Analysis 2026 latest depth analysis market research report. Global Chronic Obstructive Pulmonary Disease Drugs Market Report contains comprehensive information about current market situation impacted by COVID-19, forecast growth, segments that have most impacted by COVID-19, and Emerging Trends in 2020. Report also discusses Chronic Obstructive Pulmonary Disease Drugs business growth strategies, competitive analysis, regional market insights, emerging key companies in market.

Report segments information on Global Chronic Obstructive Pulmonary Disease Drugs By Drug Class (Bronchodilators, Steroids, Combination drugs), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), and Geography Forecast till 2026.

Get Sample Report Copy On COVID-19 Impact On Global Chronic Obstructive Pulmonary Disease Drugs Market

Global Chronic Obstructive

Read More

Global Sickle Cell Disease Treatments Market 2020 Business Growth Rate, Manufacturing Analysis, Size, Share, Cost Structure and Forecast to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 22, 2020 (CDN Newswire via Comtex) —
Global Sickle Cell Disease Treatments Market 2020 by Company, Regions, Type and Application, Forecast to 2025 is the most important research that contains an inside-out and expert examination of the market. The report covers sheds light on old and future trends for market demand, size, trading, supply, competitors, and prices as well as global predominant vendors’ information. The report also puts forward insights into the market size, crucial markers, review, as well as the most recent net edge, income, types, patterns, along with provincial figures and examination. The expert team of researchers throws light on various static as well as dynamic aspects of the global Sickle Cell Disease Treatments market. The report sorts the global market by the end client, type, area, and top players/brands. The leading performers of

Read More

Graft Versus Host Disease Treatment Market Share, Business Opportunities, Global Trends, Industry Size, Growth , and Demand Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 14, 2020 (The Expresswire) —
The global “Graft Versus Host Disease Treatment Market Size” is slated to experience a rugged expansion period on account of rising number of allogenic bone marrow and stem cell transplants. Fortune Business Insights offers valuable market analysis in its report, titled “Graft versus Host Disease (GvHD) Treatment Market Size, Share and Global Trend By Type (Acute Graft Versus Host Disease (aGvHD), Chronic Graft Versus Host Disease (cGvHD)), By Treatment (mTOR Inhibitors, Tyrosine Kinase Inhibitors, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026”. Factors that will influence the prevalent trends in the market trends have been carefully assessed in the report.

Leading Players operating in the Graft versus Host Disease (GvHD) Treatment Market are:

Key players are involved in mergers and acquisition to

Read More

A top disease expert is warning of ‘another 12 to 14 months of a really hard road ahead of us,’ and says the US has no national plan to stop it



a man wearing a suit and tie: Dr. Michael Osterholm on Sunday said the US doesn't have a national plan to stop the spread of COVID in the fall and winter. Meet The Press/NBC News


© Meet The Press/NBC News
Dr. Michael Osterholm on Sunday said the US doesn’t have a national plan to stop the spread of COVID in the fall and winter. Meet The Press/NBC News

  • Michael Osterholm, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, warned of a potential spike in cases of novel coronavirus this fall and said the US has “another 12 to 14 months of a really hard road ahead.”
  • Osterholm, who made the comments Sunday on NBC News’ “Meet The Press,” said while a COVID-19 vaccine could become available, it wouldn’t have a “meaningful” impact until 2021 at the earliest.
  • Last week, Dr. Anthony Fauci, the top US infectious disease expert, said Americans should expect to “hunker down” in the upcoming fall and winter months.
  • “What is our national plan?” Osterholm asked. “We don’t have one.” 
  • Visit Business Insider’s homepage
Read More